학술논문

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Document Type
Article
Author
Mok, Tony S KWu, Yi-LongKudaba, IvetaKowalski, Dariusz MCho, Byoung ChulTurna, Hande ZCastro, GilbertoSrimuninnimit, VichienLaktionov, Konstantin KBondarenko, IgorKubota, KaoruLubiniecki, Gregory MZhang, JinKush, DebraLopes, GilbertoAdamchuk, GrigoryAhn, Myung-JuAlexandru, AureliaAltundag, OzdenAlyasova, AnnaAndrusenko, OrestAoe, KeisukeAraujo, AntonioAren, OsvaldoArrieta Rodriguez, OscarAtivitavas, TouchAvendano, OscarBarata, FernandoBarrios, Carlos HenriqueBeato, CarlosBergstrom, PerBetticher, DanielBolotina, LarisaBondarenko, IgorBotha, MichielBuddu, SayeuriCaglevic, ChristianCardona, AndresCastro, GilbertoCastro, HugoCay Senler, FilizCerny, Carlos Alexandre SydowCesas, AlvydasChan, Gee-ChenChang, JianhuaChen, GongyanChen, XiCheng, SusannaCheng, YingCherciu, NellyChiu, Chao-HuaCho, Byoung ChulCicenas, SauliusCiurescu, DanielCohen, GrahamCosta, Marcos AndreDanchaivijitr, PongwutDe Angelis, Flaviade Azevedo, Sergio JobimDediu, MirceaDeliverski, TsvetanDe Marchi, Pedro Rafael Martinsde The Bustamante Valles, FlorDing, ZhenyuDoganov, BoyanDreosti, LydiaDuarte, RicardoEdusma-Dy, ReginaEmelyanov, SergeyErman, MustafaFan, YunFein, LuisFeng, JifengFenton, DavidFernandes, GustavoFerreira, CarlosFranke, Fabio AndreFreitas, HelanoFujisaka, YasuhitoGalindo, HectorGalvez, ChristinaGanea, DoinaGil, NunoGirotto, GustavoGoker, ErdemGoksel, TuncayGomez Aubin, GonzaloGomez Wolff, LuisGriph, HakanGumus, MahmutHall, JacquelineHart, GregoryHavel, LiborHe, JianxingHe, YongHernandez Hernandez, CarlosHespanhol, VenceslauHirashima, TomonoriHo, Chung Man JamesHoriike, AtsushiHosomi, YukioHotta, KatsuyukiHou, MeiHow, Soon HinHsia, Te-ChunHu, YiIchiki, MasaoImamura, FumioIvashchuk, OleksandrIwamoto, YasuoJaal, JanaJassem, JacekJordaan, ChristaJuergens, Rosalyn AnneKaen, DiegoKalinka-Warzocha, EwaKaraseva, NinaKaraszewska, BoguslawaKazarnowicz, AndrzejKasahara, KazuoKatakami, NobuyukiKato, TerufumiKawaguchi, TomoyaKim, Joo HangKishi, KazumaKolek, VitezslavKoleva, MarchelaKolman, PetrKoubkova, LeonaKowalyszyn, RubenKowalski, DariuszKoynov, KrassimirKsienski, DoranKubota, KaoruKudaba, IvetaKurata, TakayasuKuusk, GerliKuzina, LyudmilaLaczo, IbolyaLadrera, Guia Elena ImeldaLaktionov, KonstantinLanders, GregoryLazarev, SergeyLerzo, GuillermoLesniewski Kmak, KrzysztofLi, WeiLiam, Chong KinLifirenko, IgorLipatov, OlegLiu, XiaoqingLiu, ZheLo, Sing HungLopes, ValeriaLopez, KarlaLu, ShunMartinengo, GastonMas, LuisMatrosova, MarinaMicheva, RumyanaMilanova, ZhasminaMiron, LucianMok, TonyMolina, MatiasMurakami, ShujiNakahara, YasuharuNguyen, Tien QuangNishimura, TakashiOchsenbein, AdrianOhira, TatsuoOhman, RonnyOng, Choo KhoonOstoros, GyulaOuyang, XuenongOvchinnikova, ElenaOzyilkan, OzgurPetruzelka, LubosPham, Xuan DungPicon, PabloPiko, BelaPoltoratsky, ArtemPonomarova, OlgaPopelkova, PatricePurkalne, GuntaQin, ShukuiRamlau, RodrygRappaport, BernardoRey, FelipeRichardet, EduardoRoubec, JaromirRuff, PaulRusyn, AndriiSaka, HideoSalas, JorgeSandoval, MarioSantos, LucasSawa, ToshiyukiSeetalarom, KasanSeker, MesutSeki, NobuhikoSeolwane, FreddyShepherd, LucindaShevnya, SergiiShimada, Andrea KazumiShparyk, YaroslavSinielnikov, IvanSirbu, DanielaSmaletz, OrenSoares, Joao Paulo HolandaSookprasert, AumkhaeSperanza, GiovannaSrimuninnimit, VichienSriuranpong, ViroteStara, ZinaidaSu, Wu-ChouSugawara, ShunichiSzpak, WaldemarTakahashi, KazuhisaTakigawa, NagioTanaka, HiroshiTan Chun Bing, JerryTang, QiyouTaranov, PavelTejada, HermesTho, Lye MunTorii, YoshitaroTrukhyn, DmytroTurdean, MariaTurna, HandeUrsol, GrygoriyVanasek, JaroslavVarela, MirtaVallejo, MarcelaVera, LuisVictorino, Ana-PaulaVlasek, TomasVynnychenko, IhorWang, BuhaiWang, JieWang, KaiWu, YilongYamada, KazuhikoYang, Chih-HsinYokoyama, TakumaYokoyama, ToshihideYoshioka, HiroshigeYumuk, FuldenZambrano, AngelaZarba, Juan JoseZarubenkov, OlegZemaitis, MariusZhang, LiZhang, LiZhang, XinZhao, JunZhou, CaicunZhou, JianyingZhou, QingZippelius, Alfred
Source
The Lancet; May 2019, Vol. 393 Issue: 10183 p1819-1830, 12p
Subject
Language
ISSN
01406736; 1474547X
Abstract
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a programmed death ligand 1 (PD-L1) tumour proportion score (TPS) of 50% or greater. We investigated overall survival after treatment with pembrolizumab monotherapy in patients with a PD-L1 TPS of 1% or greater.